In Situ Liquid‐Liquid Phase Separation of Peptides Into Droplets Targeting Membraneless Organelles for Enhanced Cancer Chemotherapy
Advanced Materials · 2025-07 · 37 (28)
DOI: 10.1002/adma.202420399 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 07.05.2025. Verfasst von Weishu Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Functional Polymer Materials, Ministry of Education, State Key Laboratory of Medicinal Chemical Biology, Institute of Polymer Chemi…. Hauptthemen laut MEDLINE: Organelles, Peptides, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Beijing-Tianjin-Hebei Basic Research Cooperation Project, Haihe Laboratory of Sustainable Chemical Transformations, Tianjin Municipal Science and Technology Committee.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Liquid‐liquid phase separation (LLPS) of proteins and nucleic acids into membraneless organelles (MLOs) plays a critical role in sustaining fundamental physiological processes. However, creating artificial coacervate droplets in living cells from exogenous molecules and modulating the functions of MLOs remain challenging. To address this concern, here we reported enzyme‐induced in situ phase separation of peptides into droplets targeting MLO stress granule (SG) for enhanced cancer chemotherapy. The peptide Y SO4 F containing two sulfated tyrosine residues undergoes sulfatase‐responsive LLPS into droplets. Cellular studies confirm in situ phase separation of Y SO4 F selectively in sulfatase‐overexpressing cancer cells. By integrating with appropriate ligands, the in situ‐formed droplets d‐YF‐L SG coacervate with SGs driven by association between the ligand with SG key component protein G3BP2. Mechanistic studies illustrate that the in situ‐formed droplets enhance the cytotoxicity of sorafenib via activating caspase‐dependent apoptosis. Furthermore, animal experiments confirm that administration of the in situ‐formed droplets with sorafenib significantly inhibits tumor growth in murine models bearing tumors, accompanied by an excellent biosafety profile. The findings in this study elucidate an innovative approach for in situ formulation of coacervate droplets within tumor cells and a new material for targeting membraneless organelles, thus providing a promising new strategy for disease organelle‐targeted therapy in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Functional Polymer Materials, Ministry of Education, State Key Laboratory of Medicinal Chemical Biology, Institute of Polymer Chemistry, College of Chemistry, Nankai University, 94 Weijin Road, Tianjin…
- Applied Oral Sciences and Community Dental Care, Faculty of Dentistry, The University of Hong Kong, Hong Kong S.A.R., 999077, China.
- Haihe Laboratory of Sustainable Chemical Transformations, Tianjin, 300192, China.
ORCID-Profile: Zhilin Yu
Förderung
- Beijing-Tianjin-Hebei Basic Research Cooperation Project
- Haihe Laboratory of Sustainable Chemical Transformations
- Tianjin Municipal Science and Technology Committee
- National Natural Science Foundation of China
- Haihe Laboratory of Synthetic Biology
Zitieren
APA
Wang, W., Wang, H., Zhang, Z., Liu, X., Hu, B., Tian, F., Ye, Z., Shi, L., & Yu, Z. (2025). In Situ Liquid‐Liquid Phase Separation of Peptides Into Droplets Targeting Membraneless Organelles for Enhanced Cancer Chemotherapy. Advanced Materials, 37(28). https://doi.org/10.1002/adma.202420399
Vancouver
Wang W, Wang H, Zhang Z, Liu X, Hu B, Tian F, et al. In Situ Liquid‐Liquid Phase Separation of Peptides Into Droplets Targeting Membraneless Organelles for Enhanced Cancer Chemotherapy. Advanced Materials. 2025;37(28). doi:10.1002/adma.202420399
BibTeX
@article{Wang2025,
author = {Wang, Weishu and Wang, Hao and Zhang, Zeyu and Liu, Xin and Hu, Binbin and Tian, Feng and Ye, Zhou and Shi, Linqi and Yu, Zhilin},
title = {In Situ Liquid‐Liquid Phase Separation of Peptides Into Droplets Targeting Membraneless Organelles for Enhanced Cancer Chemotherapy},
journal = {Advanced Materials},
year = {2025},
volume = {37},
number = {28},
doi = {10.1002/adma.202420399}
}
EUVIMED